The global roadmap for advancing development of vaccines against sexually transmitted infections: Update and next steps

Sami L. Gottlieb*, Carolyn D. Deal, Birgitte Giersing, Helen Rees, Gail Bolan, Christine Johnston, Peter Timms, Scott D. Gray-Owen, Ann E. Jerse, Caroline E. Cameron, Vasee S. Moorthy, James Kiarie, Nathalie Broutet

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

115 Scopus citations

Abstract

In 2014, the World Health Organization, the US National Institutes of Health, and global technical partners published a comprehensive roadmap for development of new vaccines against sexually transmitted infections (STIs). Since its publication, progress has been made in several roadmap activities: obtaining better epidemiologic data to establish the public health rationale for STI vaccines, modeling the theoretical impact of future vaccines, advancing basic science research, defining preferred product characteristics for first-generation vaccines, and encouraging investment in STI vaccine development. This article reviews these overarching roadmap activities, provides updates on research and development of individual vaccines against herpes simplex virus, Chlamydia trachomatis, Neisseria gonorrhoeae, and Treponema pallidum, and discusses important next steps to advance the global roadmap for STI vaccine development.

Original languageEnglish
Pages (from-to)2939-2947
Number of pages9
JournalVaccine
Volume34
Issue number26
DOIs
StatePublished - 3 Jun 2016
Externally publishedYes

Keywords

  • Roadmap
  • Sexually transmitted infections
  • STI vaccine development
  • Vaccines

Cite this